EXODERIL

This brand name is authorized in Austria, Croatia, Estonia, Hong Kong SAR China, Lithuania, Poland, Romania, Turkey.

Active ingredients

The drug EXODERIL contains one active pharmaceutical ingredient (API):

1	Naftifine UNII 25UR9N9041 - NAFTIFINE HYDROCHLORIDE
	Naftifine is a topical antifungal drug. it is used for the the treatment of interdigital tinea pedis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.
	Read more about Naftifine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AE22	Naftifine	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AE Other antifungals for topical use
Discover more medicines within D01AE22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1020306, 1061075, 1061086, 1061110, 1722990
HK	Department of Health Drug Office	53383
HR	Agencija za lijekove i medicinske proizvode	HR-H-018415172, HR-H-214099122
LT	Valstybinė vaistų kontrolės tarnyba	1003009, 1003010, 1003011, 1074962, 1080372
PL	Rejestru Produktów Leczniczych	100087245
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W41598001, W41599001, W41599002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699502650329, 8699516350680, 8699516510695